Cilostamide
SIGMA/C7971 - phosphodiesterase inhibitor
Synonym: 6-
CAS Number: 68550-75-4
Empirical Formula (Hill Notation): C20H26N2O3
Molecular Weight: 342.43
MDL Number: MFCD00673958
Linear Formula: C20H26N2O3
Product Type: Chemical
| assay | ≥97% (HPLC) |
| form | powder |
| InChI | 1S/C20H26N2O3/c1-22(16-6- |
| InChI key | UIAYVIIHMORPSJ-UHFFFAOYSA |
| Quality Level | 100 ![]() |
| SMILES string | CN(C1CCCCC1)C(=O)CCCOc2cc |
| solubility | DMSO: 20 mg/mL, clear, colorless to faintly yellow |
| Biochem/physiol Actions: | PDE3 catalyzes the phosphodiester bond hydrolysis, observed in secondory messengers such as cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). Inhibitors of PDE3 are generally inotropic and vasodilatory. They are being recognized for its use in treating heart failures. Cilostamide is known to delay meiotic progression. |
| Biochem/physiol Actions: | Selective cGMP-inhibited phosphodiesterase inhibitor (PDE3); IC50 = 70 ± 9 nM. |
| Biochem/physiol Actions: | Selective inhibitor of PDE3 (cGMP-inhibited phosphodiesterase); IC50 = 70 ± 9 nM. This inhibitory effect increases intracellular cAMP and inhibits platelet aggregation. |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥97% (HPLC) |
| UNSPSC | 12352202 |

